EPO reaffirms revocation of broad Viagra patent

The European Patent Office has reaffirmed a previous ruling revoking a broad Pfizer patent covering erectile dysfunction drugs, which Pfizer sought to use to keep Cialis and Levitra from competing with Viagra in Europe.